Request Demo
Last update 08 May 2025
Tobramycin/Edetate Calcium sodium
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Tobramycin + CaEDTA, Tobramycin + Calcium EDTA, Tobramycin + Sodium calcium edetate + [3] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), Chelating agents |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC10H14CaN2NaO9 |
InChIKeyMUBDSQWHVCAGNW-UHFFFAOYSA-J |
CAS Registry23411-34-9 |
View All Structures (2)
Related
1
Clinical Trials associated with Tobramycin/Edetate Calcium sodiumNCT06016088
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b/2a Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection
100 Clinical Results associated with Tobramycin/Edetate Calcium sodium
Login to view more data
100 Translational Medicine associated with Tobramycin/Edetate Calcium sodium
Login to view more data
100 Patents (Medical) associated with Tobramycin/Edetate Calcium sodium
Login to view more data
100 Deals associated with Tobramycin/Edetate Calcium sodium
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute respiratory infections | Phase 2 | United States | 01 Apr 2024 | |
| Acute respiratory infections | Phase 2 | Australia | 01 Apr 2024 | |
| Pseudomonas aeruginosa infection | Phase 2 | United States | 01 Apr 2024 | |
| Pseudomonas aeruginosa infection | Phase 2 | Australia | 01 Apr 2024 | |
| Pulmonary Cystic Fibrosis | Phase 2 | Australia | 01 Apr 2024 | |
| Pulmonary Cystic Fibrosis | Phase 2 | United States | 01 Apr 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free